Company: GEHC
Filing Date: 2025-06-05
Form Type: 424B2
Source: 0001193125-25-135863
Chunk: 10

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-06-05
Form: 424B2
Chunk 10
---
.                                                                                                                                                        |

S-3

| federal income tax purposes with the notes of such series, such additional notes will have a different CUSIP, ISIN and/or any other identifying number. Any such additional notes will have the 
 same terms as to status, redemption or otherwise as the notes of the applicable series.                                                                                                         |

| Governing Law | The notes will be, and the related indenture is, governed by and construed in accordance with the laws of the State of New York. |

| Trustee | The Bank of New York Mellon. |

| Risk Factors | See “Risk Factors” beginning on page S-5 of this prospectus supplement to read 
 about important factors you should consider before buying the notes.           |

| Conflicts of Interests | Certain affiliates of the underwriters hold some of the 2025 notes being repaid and, as a result, will receive at least 5% of the net offering proceeds. See “Use of Proceeds.” Accordingly, this offering is being made in compliance with    
 the requirements of Rule 5121 of the Financial Industry Regulatory Authority Inc. (“FINRA”). In accordance with Rule 5121, the appointment of a qualified independent underwriter is not required since the notes offered are rated investment 
 grade.                                                                                                                                                                                                                                         |

S-4

RISK FACTORS

An investment in the notes involves a number of risks. You should carefully consider all the information set forth in this prospectus supplement and the accompanying prospectus and incorporated by reference herein before deciding to invest in the notes. In particular, we urge you to consider carefully the factors set forth below and in the 2024 Form 10-K,which is incorporated by reference herein (as such risk factors may be updated from time to time in our public filings). Any of these risks could materially and adversely affect our business, financial condition and results of operations and the actual outcome of matters as to which forward-looking statements are made in this prospectus supplement and the accompanying prospectus. While we believe we have identified and discussed below and in the documents incorporated by reference herein the material risks affecting our business, there may be additional risks and uncertainties that we do not presently know or that we do not currently believe to be material that may adversely affect such business, financial condition and results of operations in the future.

Risks Related to the Notes

The notes are obligations of GE HealthCare Technologies Inc. only and our operations are conducted through, and a substantial portion of our consolidated assets is held by, our subsidiaries.

The